[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336338-105":59,"doc-detail-336338-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","system-analysis-based-on-anoikis-related-genes-identifies-mapk1-as-a-novel-therapy-target-for-osteosarcoma-with-neoadjuvant-chemotherapy","System analysis based on Anoikis-related genes identifies MAPK1 as a novel therapy target for osteosarcoma with neoadjuvant chemotherapy","","Background: Osteosarcoma (OS) is the most common bone malignancy in children, with often poor outcomes, and anoikis represents a distinctive form of programmed cell death, yet its role in OS remains unclear. Methods: Anoikis-related genes were differentially analyzed between metastatic and non-metastatic groups; LASSO logistic regression and SVM-RFE screened characteristic genes, followed by univariate and multivariate Cox regression for prognostic genes and development of an anoikis-based risk score. Correlation analyses linked tumor microenvironment, drug sensitivity, and the prognostic model. Results: Novel anoikis-related subgroups and a three-gene prognostic model (MAPK1, MYC, EDIL3) were established with reliable survival and ROC performance, and single-cell data indicated strong links to immune infiltration; aberrant expression in OS cells was observed, and nilotinib promoted apoptosis while down-regulating MAPK1.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/system-analysis-based-on-anoikis-related-genes-identifies-mapk1-as-a-novel-therapy-target-for-osteosarcoma-with-neoadjuvant-chemotherapy/336338/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/system-analysis-based-on-anoikis-related-genes-identifies-mapk1-as-a-novel-therapy-target-for-osteosarcoma-with-neoadjuvant-chemotherapy/336338.png","ImageObject",300,407,{"name":92,"@type":93},"Hazel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the purpose of analyzing Anoikis-related genes in osteosarcoma?","Question",{"text":112,"@type":113},"The study aims to clarify the effects of anoikis in osteosarcoma and identify genes that hinder treatment response, enabling development of prognostic indicators and more effective targeted therapies.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were characteristic genes screened and prognostic models constructed?",{"text":117,"@type":113},"Differential analysis compared metastatic versus non-metastatic groups, then LASSO logistic regression and SVM-RFE screened characteristic genes. Univariate and multivariate Cox regression identified prognostic genes and supported construction of an anoikis-based risk score.",{"name":119,"@type":110,"acceptedAnswer":120},"What does the three-gene prognostic model (MAPK1, MYC, EDIL3) show?",{"text":121,"@type":113},"The model created novel anoikis-related subgroups and demonstrated reliable survival and ROC performance, suggesting it can stratify osteosarcoma prognosis. Single-cell analysis further indicated close association of these genes with immune cell infiltration.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336338,1790146392,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","Wu et al. BMC Musculoskeletal Disorders (2024) 25:437  \n[https://doi.org/10.1186/s12891-024-07547-2](https://doi.org/10.1186/s12891-024-07547-2)  \nBMC Musculoskeletal Disorders  \nRESEARCH Open Access  \nSystem analysis based on Anoikis-related genes identifies MAPK1 as a novel therapy target for osteosarcoma with neoadjuvant chemotherapy  \nZhouwei Wu 1,3†, Jiapei Yu 1,3†, Tao Han2,3†, Yiting Tu 1,3, Fang Su 1, Shi Li 1,3,4* and Yixing Huang 1,3*  \nAbstract  \nBackground Osteosarcoma (OS) is the most common bone malignant tumor in children, and its prognosis is often poor. Anoikis is a unique mode of cell death. However, the effects of Anoikis in OS remain unexplored.  \nMethod Differential analysis of Anoikis-related genes was performed based on the metastatic and non-metastatic groups. Then LASSO logistic regression and SVM-RFE algorithms were applied to screen out the characteristic genes. Later, Univariate and multivariate Cox regression was conducted to identify prognostic genes and further develop the Anoikis-based risk score. In addition, correlation analysis was performed to analyze the relationship between tumor microenvironment, drug sensitivity, and prognostic models.  \nResults We established novel Anoikis-related subgroups and developed a prognostic model based on three Anoikisrelated genes (MAPK1, MYC, and EDIL3) . The survival and ROC analysis results showed that the prognostic model was reliable. Besides, the results of single-cell sequencing analysis suggested that the three prognostic genes were closely related to immune cell infiltration. Subsequently, aberrant expression of two prognostic genes was identified in osteosarcoma cells. Nilotinib can promote the apoptosis of osteosarcoma cells and down-regulate the expression of MAPK1 .  \nConclusions We developed a novel Anoikis-related risk score model, which can assist clinicians in evaluating the prognosis of osteosarcoma patients in clinical practice. Analysis of the tumor immune microenvironment and chemotherapeutic drug sensitivity can provide necessary insights into subsequent mechanisms. MAPK1 may be a valuable therapeutic target for neoadjuvant chemotherapy in osteosarcoma.  \nKeywords Anoikis, MAPK1, Osteosarcoma, Prognostic model, Drug resistance  \n†Zhouwei Wu, Jiapei Yu and Tao Han contributed equally to this work.  \n*Correspondence: Shi Li [lister@wmu.edu.cn](lister@wmu.edu.cn)[ ](lister@wmu.edu.cn)Yixing Huang [hyxquality@163.com](hyxquality@163.com)  \n1Department of Orthopedics, the Second Affiliated Hospital, Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou 325000, China  \n2Department of Orthopedics, the Shaoxing People’s Hospital (Shaoxing Hospital of Zhejiang University), Shaoxing 312000, China  \n3Key Laboratory of Orthopedics of Zhejiang Province, Wenzhou 325000, China  \n4Department of Orthopaedics, The Second Affiliated Hospital, Yuying Children’s Hospital of Wenzhou Medical University, 109 West Xueyuan Road, Wenzhou 325027, Zhejiang Province, China  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ([http://creativecommons.org/publicdomain","cbCaii7t1Fqjv8oo","https://ap.wps.com/l/cbCaii7t1Fqjv8oo","pdf",3528915,14,"English","# Abstract\n# Introduction\n## Disease background and treatment challenges\n## Anoikis biology and its relevance to cancer\n# Methods\n# Results\n# Conclusions","[{\"question\":\"What is the purpose of analyzing Anoikis-related genes in osteosarcoma?\",\"answer\":\"The study aims to clarify the effects of anoikis in osteosarcoma and identify genes that hinder treatment response, enabling development of prognostic indicators and more effective targeted therapies.\"},{\"question\":\"How were characteristic genes screened and prognostic models constructed?\",\"answer\":\"Differential analysis compared metastatic versus non-metastatic groups, then LASSO logistic regression and SVM-RFE screened characteristic genes. Univariate and multivariate Cox regression identified prognostic genes and supported construction of an anoikis-based risk score.\"},{\"question\":\"What does the three-gene prognostic model (MAPK1, MYC, EDIL3) show?\",\"answer\":\"The model created novel anoikis-related subgroups and demonstrated reliable survival and ROC performance, suggesting it can stratify osteosarcoma prognosis. Single-cell analysis further indicated close association of these genes with immune cell infiltration.\"}]","System analysis based on Anoikis-related genes identifies MAPK1 as a novel therapy target for osteosarcoma with neoadjuvant chemotherapy | PDF",1790014599,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/134d4adf08fcc50b3c4b2de86b654cfe.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e69f2c0aae56a24e2c3610fc6f3a89ed.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/500447f5cce06be43f1c46c4d651f664.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ba6069cf18bc0707119ac088f6e76742.webp",980,1306]